⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,836.85
−0.25%
FTSE ADX
9,844.84
+0.63%
TASI
9,979.55
−1.42%
QE Index
8,645.16
+0.14%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,807.43
−0.10%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.00
+1.99%
SAU:2222
SAR 25.64
−0.62%
DSMD:QNBK
QAR 15.48
−1.15%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.50
+0.34%
Gold
$4,121.77
−0.46%
Brent
$110.64
+1.30%
BTC
$81,435.46
−0.50%
ETH
$2,384.65
−0.85%
DFM General
5,836.85
−0.25%
FTSE ADX
9,844.84
+0.63%
TASI
9,979.55
−1.42%
QE Index
8,645.16
+0.14%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,807.43
−0.10%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.00
+1.99%
SAU:2222
SAR 25.64
−0.62%
DSMD:QNBK
QAR 15.48
−1.15%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.50
+0.34%
Gold
$4,121.77
−0.46%
Brent
$110.64
+1.30%
BTC
$81,435.46
−0.50%
ETH
$2,384.65
−0.85%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Arrowhead Pharmaceuticals Inc · News · TradingHolo
Markets
›
United States
› NAS
› ARWR
A
Arrowhead Pharmaceuticals Inc
NAS:ARWR
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
$57.23
+2.38%
At close
At close · Tue 20 Oct · ≈
AED 210.18
· Market cap
$8.08B
· Next earnings
Mon 30 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
ARWR news
Headlines tagged to this company
RE
Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
Reuters · 17 h ago
DO
Arrowhead Pharmaceuticals Price Target Maintained With a $115.00/Share by Chardan Capital
Dow Jones Newswires · 4 d ago
DO
Arrowhead Pharmaceuticals Price Target Maintained With a $120.00/Share by HC Wainwright & Co.
Dow Jones Newswires · 4 d ago
DO
Arrowhead Pharmaceuticals Price Target Raised to $109.00/Share From $63.00 by UBS
Dow Jones Newswires · 4 d ago
TR
Chardan Capital maintains Buy rating on Arrowhead Pharma, $115 price target
TradingView · 5 d ago
TR
HC Wainwright & Co. reiterates Buy rating on Arrowhead Pharma, $120 price target
TradingView · 5 d ago
ST
Arrowhead’s Alzheimer’s Drug Shows Sharp Reduction In Disease-Linked Protein In Early Trial – Here’s What Investors Need To Know
Stocktwits · 6 d ago
SE
Arrowhead spikes after early-stage trial data for Alzheimer’s disease
Seeking Alpha · 6 d ago
RE
Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
Reuters · 6 d ago
TR
Arrowhead Pharmaceuticals, Inc. (ARWR) Reports Up to 85% CSF Tau Reduction in Phase 1/2a
TradingView · 6 d ago
ST
Stocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist
Stocktwits · 8 d ago
SE
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show
Seeking Alpha · 11 d ago
RE
Arrowhead Pharmaceuticals Granted Entry In The FDA Star Pilot Program For Plozasiran In Severe Hypertriglyceridemia
Reuters · 13 d ago
TR
Arrowhead Pharmaceuticals, Inc. (ARWR) Plozasiran sNDA Accepted Into FDA STAR Program
TradingView · 13 d ago
SE
These healthcare stocks stand out with A+ growth grades
Seeking Alpha · 15 d ago
SE
These ten healthcare stocks posted the biggest one-month losses
Seeking Alpha · 19 d ago
BU
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
BusinessWire · 21 d ago
ST
ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near
stocktwits · 26 d ago
More news →